Literature DB >> 29392568

Effects of Human Sulfotransferase 2A1 Genetic Polymorphisms 3 on the Sulfation of Tibolone.

Ethan Miller1, Munaf H Zalzala1,2, Maryam S Abunnaja1, Katsuhisa Kurogi1,3, Yoichi Sakakibara3, Masahito Suiko3, Ming-Cheh Liu4.   

Abstract

BACKGROUND AND OBJECTIVES: Previous studies have demonstrated the metabolism of tibolone through sulfation, with the cytosolic sulfotransferase (SULT) SULT2A1 as the major responsible enzyme. The current study aimed to investigate how SULT2A1 genetic polymorphisms may affect the dehydroepiandrosterone (DHEA)- and tibolone-sulfating activity of SULT2A1.
METHODS: Site-directed mutagenesis was employed to generate cDNAs encoding ten different SULT2A1 allozymes. Recombinant SULT2A1 allozymes were expressed in BL21 E. coli cells, and purified using glutathione-sepharose affinity chromatography. An established sulfotransferase assay was used to analyze DHEA- and tibolone-sulfating activity of the purified SULT2A1 allozymes.
RESULTS: The nine human SULT2A1 allozymes plus the wild-type SULT2A1 were found to display differential sulfating activity toward DHEA and tibolone. Kinetic analysis revealed that different SULT2A1 allozymes exhibited differential substrate affinity and catalytic efficiency toward the two substrates tested.
CONCLUSION: The results obtained provided useful information concerning the differential metabolism of tibolone through sulfation in individuals with different SULT2A1 genotypes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29392568      PMCID: PMC6041190          DOI: 10.1007/s13318-017-0458-2

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  24 in total

1.  Biological sulfate activation and transfer.

Authors:  F LIPMANN
Journal:  Science       Date:  1958-09-12       Impact factor: 47.728

Review 2.  Structure, function and polymorphism of human cytosolic sulfotransferases.

Authors:  Julian Lindsay; Lin-Lin Wang; Yong Li; Shu-Feng Zhou
Journal:  Curr Drug Metab       Date:  2008-02       Impact factor: 3.731

3.  cDNA cloning, expression, and characterization of the human bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate kinase enzyme.

Authors:  K Yanagisawa; Y Sakakibara; M Suiko; Y Takami; T Nakayama; H Nakajima; K Takayanagi; Y Natori; M C Liu
Journal:  Biosci Biotechnol Biochem       Date:  1998-05       Impact factor: 2.043

Review 4.  Sulfotransferase genetic variation: from cancer risk to treatment response.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Drug Metab Rev       Date:  2013-09-06       Impact factor: 4.518

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies.

Authors:  B A Thomae; B W Eckloff; R R Freimuth; E D Wieben; R M Weinshilboum
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

7.  Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.

Authors:  Eva Lundström; Alexander Christow; Wendy Kersemaekers; Gunilla Svane; Edward Azavedo; Gunnar Söderqvist; Mirjam Mol-Arts; Jan Barkfeldt; Bo von Schoultz
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

8.  Human liver dehydroepiandrosterone sulfotransferase: nature and extent of individual variation.

Authors:  I A Aksoy; V Sochorová; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1993-11       Impact factor: 6.875

Review 9.  Tibolone: a unique version of hormone replacement therapy.

Authors:  John M Swegle; Michael W Kelly
Journal:  Ann Pharmacother       Date:  2004-03-16       Impact factor: 3.154

10.  Cloning and expression of human liver dehydroepiandrosterone sulphotransferase.

Authors:  K A Comer; J L Falany; C N Falany
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

View more
  2 in total

Review 1.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 2.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.